AngioDynamics Revenue vs. Current Valuation

ANGO Stock  USD 6.26  0.14  2.29%   
Based on AngioDynamics' profitability indicators, AngioDynamics may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in May. Profitability indicators assess AngioDynamics' ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2001-08-31
Previous Quarter
79.1 M
Current Value
75.2 M
Quarterly Volatility
29.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
At this time, AngioDynamics' Days Sales Outstanding is very stable compared to the past year. As of the 23rd of April 2024, EV To Sales is likely to grow to 2.49, while Price To Sales Ratio is likely to drop 1.20. At this time, AngioDynamics' Change To Netincome is very stable compared to the past year. As of the 23rd of April 2024, Net Income Per E B T is likely to grow to 0.95, though Accumulated Other Comprehensive Income is likely to grow to (5.2 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.590.5144
Fairly Up
Slightly volatile
For AngioDynamics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AngioDynamics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AngioDynamics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AngioDynamics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AngioDynamics over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.80)
Revenue Per Share
8.105
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.05)
Return On Equity
(0.62)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

AngioDynamics Current Valuation vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining AngioDynamics's current stock value. Our valuation model uses many indicators to compare AngioDynamics value to that of its competitors to determine the firm's financial worth.
AngioDynamics is rated second in revenue category among related companies. It is rated below average in current valuation category among related companies reporting about  0.52  of Current Valuation per Revenue. The ratio of Revenue to Current Valuation for AngioDynamics is roughly  1.92 . At this time, AngioDynamics' Total Revenue is very stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value AngioDynamics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AngioDynamics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AngioDynamics' earnings, one of the primary drivers of an investment's value.

AngioDynamics Revenue vs. Competition

AngioDynamics is rated second in revenue category among related companies. Market size based on revenue of Health Care industry is presently estimated at about 2.31 Billion. AngioDynamics retains roughly 338.75 Million in revenue claiming about 15% of equities under Health Care industry.

AngioDynamics Current Valuation vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

AngioDynamics

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
338.75 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

AngioDynamics

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
176.26 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

AngioDynamics Current Valuation vs Competition

AngioDynamics is rated below average in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 10.62 Billion. AngioDynamics claims roughly 176.26 Million in current valuation contributing just under 2% to equities under Health Care industry.

AngioDynamics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in AngioDynamics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AngioDynamics will eventually generate negative long term returns. The profitability progress is the general direction of AngioDynamics' change in net profit over the period of time. It can combine multiple indicators of AngioDynamics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-5.4 M-5.2 M
Operating Income-17.3 M-16.4 M
Income Before Tax-49 M-46.5 M
Total Other Income Expense Net-31.7 M-30.1 M
Net Loss-47.2 M-44.8 M
Income Tax Expense-1.8 M-1.7 M
Net Loss-47.2 M-44.8 M
Net Loss-47.2 M-44.8 M
Non Operating Income Net Other-637.1 K-669 K
Net Interest Income-3.1 M-3.3 M
Interest Income816.3 K775.5 K
Change To Netincome32.8 M34.4 M
Net Loss(1.53)(1.45)
Income Quality(0)(0)
Net Income Per E B T 0.87  0.95 

AngioDynamics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on AngioDynamics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AngioDynamics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AngioDynamics' important profitability drivers and their relationship over time.

Use AngioDynamics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.

AngioDynamics Pair Trading

AngioDynamics Pair Trading Analysis

The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.
The correlation of AngioDynamics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your AngioDynamics position

In addition to having AngioDynamics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Housewares Thematic Idea Now

Housewares
Housewares Theme
Companies making housewares accessories and providing houseware services. The Housewares theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Housewares Theme or any other thematic opportunities.
View All  Next Launch
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out Trending Equities.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Transaction History
View history of all your transactions and understand their impact on performance
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Fundamental Analysis
View fundamental data based on most recent published financial statements
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
To fully project AngioDynamics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AngioDynamics at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AngioDynamics' income statement, its balance sheet, and the statement of cash flows.
Potential AngioDynamics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although AngioDynamics investors may work on each financial statement separately, they are all related. The changes in AngioDynamics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on AngioDynamics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.